Did you know? You can suggest edits to improve this peptide information.
Overview
What is MK-677?
MK-677 (Ibutamoren) is a selective ghrelin receptor agonist that stimulates growth hormone release without suppressing natural production. This orally active compound increases IGF-1 levels, improves sleep quality, and supports body composition changes through sustained growth hormone elevation.
Key Benefits
97% increase in 24-hour growth hormone secretion, 40-72% IGF-1 elevation, improved sleep quality, enhanced body composition, and sustained effects without suppressing natural GH production.
Mechanism of Action
MK-677 mimics endogenous ghrelin by binding to GHS-R1a receptors in the hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns. Superior >60% oral bioavailability eliminates injection requirements with 24-hour half-life enabling once-daily dosing.
Research Indications
Muscle Preservation
Reverses diet-induced catabolism with +2.69g/day nitrogen retention vs -8.97g/day placebo, supporting muscle preservation during caloric restriction.
Body Composition
Increases fat-free mass by 1.1-2.7kg over 8-12 months with preferential lean tissue accrual and 15% basal metabolic rate increase within 2 weeks.
Bone Health
39-45% increase in bone formation markers including osteocalcin within 6-8 weeks, supporting bone turnover and potential fracture prevention.
Research Protocols
Disclaimer
MK-677 is often run continuously or cycled (8-12 weeks on, 4-8 weeks off) in research settings. Some protocols start at 10mg for 1-2 weeks before increasing to 25mg to assess tolerance. Tapering when stopping is generally not reported as necessary. This is not medical advice. Consult a healthcare provider before use.
Timing
Take MK-677 at bedtime (around 10:40 PM) on empty stomach to align with natural growth hormone patterns and minimize daytime appetite stimulation. Wait 2+ hours after last meal for optimal absorption.
Peptide Interactions
How to Reconstitute
Important
Always use bacteriostatic water (BAC). Sterile technique is essential.
Take capsule 30 minutes before bedtime
Use empty stomach (2+ hours after last meal)
Swallow with full glass of water
Maintain consistent daily timing
Store capsules at room temperature in dry place
Track sleep quality and appetite changes
Quality Indicators
Pharmaceutical Grade Capsules
Professional capsules with clear labeling, batch numbers, expiration dates, and third-party testing certificates. Avoid research chemicals.
Proper Documentation
Certificate of analysis showing >98% purity, heavy metals testing, microbiological safety, and proper storage conditions during shipping.
Research Chemical Sources
Products labeled 'for research only' may have questionable quality control and are not intended for human consumption.
Dietary Supplement Claims
FDA prohibits MK-677 in dietary supplements. Any product claiming to be a legal supplement containing MK-677 is mislabeled.
Unknown Purity/Source
Products without certificates of analysis, proper labeling, or from questionable sources pose significant health and legal risks.
What to Expect
- Week 1-2: Improved sleep quality, vivid dreams, possible appetite increase
- Week 2-4: Enhanced recovery, better sleep architecture, initial body composition changes
- Week 4-8: Noticeable lean mass gains, continued sleep benefits
- Week 8-12: Maximum body composition improvements, sustained GH elevation
- Side effects: Appetite stimulation (>50%), water retention (30-40%), possible lethargy (20-30%)
Side Effects & Safety
- FDA warns of 'significant safety risks due to potential for congestive heart failure'
- Contraindicated in heart disease, diabetes, active cancer, severe cardiovascular disease
- Decreases insulin sensitivity - monitor blood glucose closely
- May cause 5-15mg/dL fasting glucose elevation
- Requires baseline and ongoing monitoring: glucose, HbA1c, liver function, IGF-1
- Not approved by FDA - investigational drug status only
References
Hip Fracture Recovery Trial - Terminated (2011)
Adunsky et al. study was terminated due to increased heart failure incidence in elderly patients, establishing critical safety limitations and contraindications for cardiovascular disease.
View Study (opens in new tab) →Bone Turnover Markers Study (1999)
Murphy et al. showed MK-677 increased bone turnover markers including osteocalcin, suggesting potential benefits for bone health through growth hormone axis activation.
View Study (opens in new tab) →Body Composition in Obese Subjects (1998)
Svensson et al. showed MK-677 increased growth hormone secretion, fat-free mass, and energy expenditure in obese subjects while maintaining effects throughout treatment duration.
View Study (opens in new tab) →Quick Start Guide
Community Poll
Question 1 of 10
What is your experience with this compound?
Poll Results
Loading results...
Community Insights
Self-reported by PepPedia users. Not clinical evidence. Health changes reflect all users, including those taking multiple compounds.
Was this helpful?
Your feedback helps us improve PepPedia